DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients? JA Roberts, SK Paul, M Akova, M Bassetti, JJ De Waele, G Dimopoulos, ... Clinical infectious diseases 58 (8), 1072-1083, 2014 | 1114 | 2014 |
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study G Grasselli, T Tonetti, A Protti, T Langer, M Girardis, G Bellani, J Laffey, ... The lancet Respiratory medicine 8 (12), 1201-1208, 2020 | 716 | 2020 |
Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic respiratory … DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro, MM Bitondo, ... Jama 325 (17), 1731-1743, 2021 | 454 | 2021 |
Intubation practices and adverse peri-intubation events in critically ill patients from 29 countries V Russotto, SN Myatra, JG Laffey, E Tassistro, L Antolini, P Bauer, ... Jama 325 (12), 1164-1172, 2021 | 389 | 2021 |
Hospital-acquired infections in critically ill patients with COVID-19 G Grasselli, V Scaravilli, D Mangioni, L Scudeller, L Alagna, M Bartoletti, ... Chest 160 (2), 454-465, 2021 | 386 | 2021 |
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae M Tumbarello, EM Trecarichi, A Corona, FG De Rosa, M Bassetti, ... Clinical Infectious Diseases 68 (3), 355-364, 2019 | 380 | 2019 |
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality M Bassetti, E Righi, F Ansaldi, M Merelli, T Cecilia, G De Pascale, ... Intensive care medicine 40, 839-845, 2014 | 310 | 2014 |
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria G De Pascale, L Montini, MA Pennisi, V Bernini, R Maviglia, G Bello, ... Critical Care 18, 1-9, 2014 | 296 | 2014 |
Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum-β-Lactamase Production and Inadequate Initial Antibiotic Therapy M Tumbarello, T Spanu, R Di Bidino, M Marchetti, M Ruggeri, ... Antimicrobial agents and chemotherapy 54 (10), 4085-4091, 2010 | 251 | 2010 |
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization … B Posteraro, G De Pascale, M Tumbarello, R Torelli, MA Pennisi, G Bello, ... Critical care 15, 1-10, 2011 | 250 | 2011 |
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study M Tumbarello, F Raffaelli, M Giannella, E Mantengoli, A Mularoni, ... Clinical Infectious Diseases 73 (9), 1664-1676, 2021 | 211* | 2021 |
Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: a randomized, placebo-controlled trial SA Quraishi, G De Pascale, JS Needleman, H Nakazawa, M Kaneki, ... Critical care medicine 43 (9), 1928-1937, 2015 | 208 | 2015 |
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality M Tumbarello, E Repetto, EM Trecarichi, C Bernardini, G De Pascale, ... Epidemiology & Infection 139 (11), 1740-1749, 2011 | 205 | 2011 |
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies DL Grieco, F Bongiovanni, L Chen, LS Menga, SL Cutuli, G Pintaudi, ... Critical Care 24, 1-11, 2020 | 200 | 2020 |
Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram … M Tumbarello, G De Pascale, EM Trecarichi, S De Martino, G Bello, ... Chest 144 (6), 1768-1775, 2013 | 199 | 2013 |
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients M Tumbarello, G De Pascale, EM Trecarichi, T Spanu, F Antonicelli, ... Intensive care medicine 39, 682-692, 2013 | 183 | 2013 |
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An … MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ... Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016 | 173 | 2016 |
Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase- Producing Escherichia coli: Risk Factors for Inadequate Initial Antimicrobial Therapy M Tumbarello, M Sali, EM Trecarichi, F Leone, M Rossi, B Fiori, ... Antimicrobial agents and chemotherapy 52 (9), 3244-3252, 2008 | 168 | 2008 |
Epidemiology of intra-abdominal infection and sepsis in critically ill patients:“AbSeS”, a multinational observational cohort study and ESICM Trials Group Project S Blot, M Antonelli, K Arvaniti, K Blot, B Creagh-Brown, D De Lange, ... Intensive care medicine 45, 1703-1717, 2019 | 153 | 2019 |
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a … R Torelli, M Sanguinetti, A Moody, L Pagano, M Caira, E De Carolis, ... Journal of Clinical Microbiology 49 (12), 4273-4278, 2011 | 150 | 2011 |